Virpax Announces Clinical Trial Site in Canada for First in Human Study of Epoladerm™ for …

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management … Read source